🇺🇸 FDA
Patent

US 8829174

HCV vaccines and methods for using the same

granted A61KA61K2039/5254A61K2039/5256

Quick answer

US patent 8829174 (HCV vaccines and methods for using the same) held by Inovio Pharmaceuticals, Inc. expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Inovio Pharmaceuticals, Inc.
Grant date
Tue Sep 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K2039/5254, A61K2039/5256, A61K2039/53, A61K2039/55